National Government Services

Quote












I feel for you guys and gals. I don't know how you live on MPQ...I would say time to start looking elsewhere. Believe me when I say that having coverage is not all that great either.
PTNS has reached the end of its rope!
 


















Nonsense. Don't try to manipulate the stock price.

1) Everyone knows that Uroplasty's stock would double if they announced NGS resumed coverage.

2) The first point is irrelevant, because NGS won't be resuming coverage. They have made it abundantly clear that they have no intent on paying for PTNS.
 






Anonymous said:
Nonsense. Don't try to manipulate the stock price.

1) Everyone knows that Uroplasty's stock would double if they announced NGS resumed coverage.

2) The first point is irrelevant, because NGS won't be resuming coverage. They have made it abundantly clear that they have no intent on paying for PTNS.
Click to expand...

wrong
 












Anonymous said:
Nonsense. Don't try to manipulate the stock price.

1) Everyone knows that Uroplasty's stock would double if they announced NGS resumed coverage.

2) The first point is irrelevant, because NGS won't be resuming coverage. They have made it abundantly clear that they have no intent on paying for PTNS.
Click to expand...

Wrong is right!
 












I would have expected NGS to post on their web site for 90 days a draft policy of their decision for positive coverage for PTNS before the coverage going into effect. I understand that is the required procedure.

I looked on their web site and see no such policy. Has anybody else seen their draft policy?
 






Anonymous said:
I would have expected NGS to post on their web site for 90 days a draft policy of their decision for positive coverage for PTNS before the coverage going into effect. I understand that is the required procedure.

I looked on their web site and see no such policy. Has anybody else seen their draft policy?
Click to expand...

I just searched PTNS on their website and saw the policy. Am I missing something?
 












Anonymous said:
Nonsense. Don't try to manipulate the stock price.

1) Everyone knows that Uroplasty's stock would double if they announced NGS resumed coverage.

2) The first point is irrelevant, because NGS won't be resuming coverage. They have made it abundantly clear that they have no intent on paying for PTNS.
Click to expand...



http://online.wsj.com/article/PR-CO-20140811-909735.html

MINNEAPOLIS, Aug. 11, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services (NGS) has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC(R) device was effective August 10, 2014.

NGS, a Medicare Administrative Contractor, provides medical and drug benefits to approximately 10 million Medicare beneficiaries in the states of New York, Illinois, Massachusetts, Wisconsin, Minnesota, Connecticut, Maine, New Hampshire, Rhode Island and Vermont.

There are over 50 million Medicare beneficiaries in the United States and all of these individuals now have access to PTNS, the only non-drug, non-surgical treatment for those who suffer from the symptoms of overactive bladder. Urgent PC is a recommended third line treatment within the OAB treatment guidelines for patients who have not responded or cannot tolerate behavioral intervention and pharmacologic agents. The treatment guidelines are issued jointly by the American Urology Association (AUA) and Society for Urodynamics and Female Urology (SUFU).

"We are pleased with the NGS positive coverage decision and excited that access to PTNS is now in place for all Medicare beneficiaries across the country. Through the efforts and collaboration of an independent physician coalition from across all ten states, NGS was able to recognize the medical necessity of PTNS and its value to patients and physicians trying to manage the symptoms of OAB," said Dan Merz, Vice President of Healthcare Affairs. "We look forward to bringing PTNS back to the many patients who had coverage in the past and to a whole new group of patients in New York and Connecticut who have never had access."

The Company will initiate increased sales and marketing efforts for PTNS in markets served by NGS during the remainder of fiscal 2015, with the Company expecting a meaningful impact on U.S. Urgent PC sales starting in fiscal 2016. The Company expects to update its fiscal 2015 guidance when it reports second quarter results
 










































Top Bottom
Back
Quote